Description and Brand Names
药物信息提供方:IBM Micromedex
US Brand Name
- Praluent
Descriptions
Alirocumab injection is used together with a proper diet and other medicines (eg, ezetimibe, statin medicine) to treat patients with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) or with homozygous familial hypercholesterolemia (HoFH), who need additional lowering of their bad cholesterol (LDL). It is also used to reduce the risk of heart attack, stroke, and unstable angina (chest pain) requiring hospitalization in adults with existing heart or blood vessel disease. This medicine is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
版权 © 2023 IBM Watson Health。保留所有权利。信息仅供终端用户使用,不得出售、重新分发或用于其他商业目的。